Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internal Medicine | 2 | 2025 | 265 | 1.520 |
Why?
|
| Point-of-Care Systems | 2 | 2025 | 167 | 1.360 |
Why?
|
| Clinical Decision-Making | 3 | 2024 | 322 | 1.220 |
Why?
|
| Infection Control | 1 | 2025 | 167 | 0.850 |
Why?
|
| Internship and Residency | 2 | 2025 | 1147 | 0.840 |
Why?
|
| Air Pollution, Indoor | 1 | 2025 | 180 | 0.810 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2020 | 110 | 0.740 |
Why?
|
| Respiratory Tract Infections | 1 | 2025 | 390 | 0.700 |
Why?
|
| Mitral Valve Stenosis | 1 | 2019 | 18 | 0.620 |
Why?
|
| Probability | 1 | 2020 | 304 | 0.610 |
Why?
|
| Likelihood Functions | 1 | 2019 | 144 | 0.610 |
Why?
|
| Endocarditis, Bacterial | 1 | 2019 | 41 | 0.600 |
Why?
|
| Curriculum | 1 | 2025 | 992 | 0.590 |
Why?
|
| Echocardiography, Doppler | 1 | 2019 | 108 | 0.580 |
Why?
|
| Dabigatran | 1 | 2018 | 22 | 0.570 |
Why?
|
| Research Design | 1 | 2024 | 1139 | 0.570 |
Why?
|
| Research Personnel | 1 | 2020 | 173 | 0.570 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 363 | 0.570 |
Why?
|
| Guidelines as Topic | 1 | 2020 | 275 | 0.560 |
Why?
|
| ROC Curve | 1 | 2019 | 554 | 0.550 |
Why?
|
| Biomedical Research | 1 | 2020 | 692 | 0.410 |
Why?
|
| Stroke | 2 | 2019 | 1120 | 0.410 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 388 | 0.410 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 1809 | 0.370 |
Why?
|
| Clinical Competence | 3 | 2025 | 1118 | 0.360 |
Why?
|
| Hospitalists | 2 | 2024 | 245 | 0.320 |
Why?
|
| Heart Failure | 2 | 2020 | 2236 | 0.310 |
Why?
|
| Patient Safety | 2 | 2024 | 314 | 0.310 |
Why?
|
| Bayes Theorem | 2 | 2022 | 405 | 0.310 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2016 | 47 | 0.250 |
Why?
|
| Humans | 23 | 2025 | 137585 | 0.240 |
Why?
|
| Air Microbiology | 1 | 2025 | 47 | 0.230 |
Why?
|
| Delphi Technique | 1 | 2025 | 280 | 0.210 |
Why?
|
| Academic Medical Centers | 2 | 2024 | 512 | 0.210 |
Why?
|
| Psychological Tests | 1 | 2024 | 140 | 0.200 |
Why?
|
| Aortic Valve | 2 | 2016 | 351 | 0.200 |
Why?
|
| Canada | 1 | 2024 | 418 | 0.200 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 534 | 0.200 |
Why?
|
| Consensus | 1 | 2025 | 683 | 0.190 |
Why?
|
| Ultrasonography | 1 | 2025 | 759 | 0.180 |
Why?
|
| Problem Solving | 1 | 2022 | 152 | 0.180 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 58 | 0.170 |
Why?
|
| Patient Satisfaction | 1 | 2024 | 660 | 0.170 |
Why?
|
| Critical Pathways | 1 | 2021 | 96 | 0.160 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2020 | 16 | 0.160 |
Why?
|
| Furosemide | 1 | 2020 | 37 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2024 | 548 | 0.160 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2019 | 3 | 0.160 |
Why?
|
| Troponin | 1 | 2019 | 50 | 0.160 |
Why?
|
| Streptococcus mutans | 1 | 2019 | 8 | 0.160 |
Why?
|
| Cryoglobulins | 1 | 2018 | 6 | 0.150 |
Why?
|
| Mycoplasma Infections | 1 | 2018 | 16 | 0.150 |
Why?
|
| Glomerulonephritis | 1 | 2019 | 47 | 0.150 |
Why?
|
| Conservative Treatment | 1 | 2019 | 33 | 0.150 |
Why?
|
| Multimorbidity | 1 | 2019 | 47 | 0.150 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2019 | 60 | 0.150 |
Why?
|
| Rheumatic Diseases | 1 | 2019 | 81 | 0.140 |
Why?
|
| United States | 2 | 2025 | 14841 | 0.140 |
Why?
|
| Educational Measurement | 1 | 2019 | 289 | 0.130 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 151 | 0.130 |
Why?
|
| Inpatients | 1 | 2021 | 500 | 0.130 |
Why?
|
| Warfarin | 1 | 2018 | 154 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 316 | 0.130 |
Why?
|
| Middle Aged | 6 | 2021 | 33479 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2019 | 271 | 0.120 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 5472 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 270 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2021 | 3457 | 0.120 |
Why?
|
| Treatment Outcome | 6 | 2022 | 10811 | 0.110 |
Why?
|
| Male | 10 | 2024 | 67762 | 0.110 |
Why?
|
| Arterio-Arterial Fistula | 1 | 2014 | 4 | 0.110 |
Why?
|
| Patient Discharge | 1 | 2021 | 897 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 1946 | 0.110 |
Why?
|
| Coronary Aneurysm | 1 | 2014 | 14 | 0.110 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2016 | 130 | 0.110 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2014 | 35 | 0.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 180 | 0.110 |
Why?
|
| Ventricular Remodeling | 1 | 2016 | 266 | 0.110 |
Why?
|
| Incidental Findings | 1 | 2014 | 87 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 229 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2018 | 664 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 382 | 0.100 |
Why?
|
| Heart Block | 1 | 2012 | 42 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2016 | 530 | 0.100 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2012 | 43 | 0.100 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2018 | 480 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2012 | 99 | 0.100 |
Why?
|
| Mitral Valve | 1 | 2012 | 88 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 1046 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 5778 | 0.090 |
Why?
|
| Heart Valve Diseases | 1 | 2012 | 151 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 2069 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5131 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2012 | 350 | 0.080 |
Why?
|
| Aged | 5 | 2020 | 23961 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 530 | 0.070 |
Why?
|
| Adult | 5 | 2022 | 37929 | 0.060 |
Why?
|
| Female | 7 | 2024 | 73304 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 889 | 0.050 |
Why?
|
| Inservice Training | 1 | 2024 | 116 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 1266 | 0.050 |
Why?
|
| Time Factors | 3 | 2016 | 6828 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2020 | 356 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2022 | 665 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2021 | 271 | 0.040 |
Why?
|
| Self Report | 1 | 2024 | 827 | 0.040 |
Why?
|
| Vibration | 1 | 2019 | 72 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 7635 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2019 | 15657 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 2828 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 513 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2022 | 1993 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2018 | 179 | 0.030 |
Why?
|
| Risk Factors | 3 | 2016 | 10388 | 0.030 |
Why?
|
| Fibrosis | 1 | 2019 | 552 | 0.030 |
Why?
|
| Diastole | 1 | 2016 | 149 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1622 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 740 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2021 | 697 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 1 | 2016 | 114 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 3295 | 0.030 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2012 | 4 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2016 | 612 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2012 | 82 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2016 | 653 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2014 | 317 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 1704 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 3284 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 530 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2016 | 1357 | 0.020 |
Why?
|
| Hospitalization | 1 | 2019 | 2199 | 0.020 |
Why?
|
| Action Potentials | 1 | 2012 | 493 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 629 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 1060 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2031 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 4149 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 2691 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3566 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 21513 | 0.010 |
Why?
|